[go: up one dir, main page]

ATE471342T1 - Parathyroidhormon analoge - Google Patents

Parathyroidhormon analoge

Info

Publication number
ATE471342T1
ATE471342T1 AT05026436T AT05026436T ATE471342T1 AT E471342 T1 ATE471342 T1 AT E471342T1 AT 05026436 T AT05026436 T AT 05026436T AT 05026436 T AT05026436 T AT 05026436T AT E471342 T1 ATE471342 T1 AT E471342T1
Authority
AT
Austria
Prior art keywords
analogue
hormon
parathyroid
parathyroid hormon
hormon analogue
Prior art date
Application number
AT05026436T
Other languages
English (en)
Inventor
Zheng Xin Dong
Original Assignee
Ipsen Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/779,768 external-priority patent/US5969095A/en
Application filed by Ipsen Pharma filed Critical Ipsen Pharma
Application granted granted Critical
Publication of ATE471342T1 publication Critical patent/ATE471342T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT05026436T 1997-01-07 1997-12-08 Parathyroidhormon analoge ATE471342T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/779,768 US5969095A (en) 1995-07-13 1997-01-07 Analogs of parathyroid hormone
US08/813,534 US5955574A (en) 1995-07-13 1997-03-07 Analogs of parathyroid hormone

Publications (1)

Publication Number Publication Date
ATE471342T1 true ATE471342T1 (de) 2010-07-15

Family

ID=27119618

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05026436T ATE471342T1 (de) 1997-01-07 1997-12-08 Parathyroidhormon analoge
AT97951595T ATE321784T1 (de) 1997-01-07 1997-12-08 Pthrp analogen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT97951595T ATE321784T1 (de) 1997-01-07 1997-12-08 Pthrp analogen

Country Status (23)

Country Link
US (1) US5955574A (de)
EP (3) EP0948541B1 (de)
JP (1) JP3963482B2 (de)
KR (2) KR100497709B1 (de)
CN (1) CN1137898C (de)
AR (3) AR011517A1 (de)
AT (2) ATE471342T1 (de)
AU (1) AU741584B2 (de)
BR (1) BR9714200A (de)
CA (1) CA2276614C (de)
CZ (2) CZ301497B6 (de)
DE (2) DE69735603T2 (de)
DK (2) DK0948541T3 (de)
ES (2) ES2258286T3 (de)
HU (1) HUP9904596A3 (de)
IL (1) IL130794A0 (de)
NO (1) NO993341L (de)
NZ (1) NZ336610A (de)
PL (1) PL191898B1 (de)
PT (2) PT948541E (de)
RU (1) RU2198182C2 (de)
SI (2) SI0948541T1 (de)
WO (1) WO1998030590A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410948B2 (en) * 1995-07-13 2008-08-12 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Analogs of parathyroid hormone
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
PL195703B1 (pl) * 1997-09-09 2007-10-31 Hoffmann La Roche Zastosowanie polipeptydowego analogu peptydu pokrewnego hormonowi przytarczyc
ATE392431T1 (de) * 1998-05-05 2008-05-15 Sod Conseils Rech Applic Pth2 rezeptor selektive verbindungen
AU3826899A (en) * 1998-07-20 2000-02-14 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Peptide analogues of pacap
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
AU2000265051A1 (en) * 2000-02-18 2001-08-27 Dabur Research Foundation Vasoactive intestinal peptide analogs
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
CA2446929C (en) * 2001-06-01 2013-04-09 Novartis Ag Orally administering parathyroid hormone and calcitonin
JP4837888B2 (ja) * 2001-07-23 2011-12-14 ザ ジェネラル ホスピタル コーポレイション コンホメーションが拘束された副甲状腺ホルモン(pth)類似体
WO2005016265A2 (en) * 2003-08-06 2005-02-24 Rhodia Inc. Method for promoting bone growth
JP2009515535A (ja) 2005-11-10 2009-04-16 ボード オブ コントロール オブ ミシガン テクノロジカル ユニヴァーシティー クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
ES2739459T3 (es) * 2006-10-03 2020-01-31 Radius Health Inc Una composición estable que comprende una proteína anabólica ósea, es decir un análogo de PTHrP y usos de la misma
MX2009003740A (es) * 2006-10-13 2009-04-22 Lilly Co Eli Pth pegilado como moduladores de receptor pth y usos de los mismos.
KR101661730B1 (ko) 2007-08-01 2016-10-04 더 제너럴 하스피탈 코포레이션 G―단백질 결합 수용체를 이용한 스크리닝 방법 및 관련 조성물
EP2411038B1 (de) 2009-03-27 2016-12-28 Van Andel Research Institute Parathryoidhormonpeptide und parathyroidhormonbezogene proteinpeptide sowie anwendungsverfahren dafür
WO2011071480A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP2568806B1 (de) 2010-05-12 2016-05-11 Radius Health, Inc. Therapiepläne
EP2569003B1 (de) 2010-05-13 2017-10-25 The General Hospital Corporation Parathyroidhormon-analoga und verwendungen davon
ES2550319T3 (es) 2010-09-28 2015-11-06 Radius Health, Inc Moduladores selectivos del receptor de andrógenos
EP3122426B1 (de) 2014-03-28 2023-01-18 Duke University Brustkrebsbehandlung mit selektiven östrogenrezeptormodulatoren
CN108135177B (zh) 2015-04-29 2021-06-01 雷迪厄斯制药公司 用于治疗癌症的方法
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
DK3474841T3 (da) 2016-06-22 2022-05-09 Ellipses Pharma Ltd Fremgangsmåder til behandling af ar+-brystkræft
ES2981967T3 (es) 2017-01-05 2024-10-14 Radius Pharmaceuticals Inc Formas polimórficas de RAD1901-2HCl
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
JP7473486B2 (ja) 2018-07-04 2024-04-23 ラジウス ファーマシューティカルズ,インコーポレイテッド Rad1901-2hclの多形形態

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
EP0293158A3 (de) * 1987-05-26 1990-05-09 Merck & Co. Inc. Parathyroide Hormon-Antagonisten
JPH03504201A (ja) * 1989-02-23 1991-09-19 ゲゼルシャフト・フュア・ビオテクノロギッシェ・フォルシュンク・ミット・ベシュレンクテル・ハフツング (ゲー・ベー・エフ) Pth変種をコードするdna配列、pth変種、発現ベクター、細菌宿主、利用と治療用組成物
CA2040264A1 (en) * 1990-04-12 1991-10-13 Tatsuhiko Kanmera Parathyroid hormone antagonists
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体
WO1993006846A1 (en) * 1991-10-10 1993-04-15 Pang Peter K T Parathyroid hormone analogues and use in osteoporosis treatment
US5434246A (en) * 1992-03-19 1995-07-18 Takeda Chemical Industries, Ltd. Parathyroid hormone derivatives
CA2098639A1 (en) * 1992-06-19 1993-12-20 K. Anne Kronis Bone stimulating, non-vasoactive parathyroid hormone variants
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
SG47043A1 (en) 1993-01-06 1998-03-20 Kinerton Ltd Ionic molecular conjugates of biodegradeble polyesters and bioactive polypeptides
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
WO1996019246A1 (en) * 1994-12-19 1996-06-27 Beth Israel Hospital Association Continuous low-dose administration of parathyroid hormone or its agonist
CA2178894A1 (en) * 1995-06-15 1996-12-16 Tsunehiko Fukuda Parathyroid hormone derivatives and their use
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
KR100497709B1 (ko) 2005-06-23
KR20000069952A (ko) 2000-11-25
CA2276614C (en) 2002-06-11
ES2347154T3 (es) 2010-10-26
CZ301497B6 (cs) 2010-03-24
AU5519998A (en) 1998-08-03
EP1645566B1 (de) 2010-06-16
US5955574A (en) 1999-09-21
AR011517A1 (es) 2000-08-30
BR9714200A (pt) 2000-03-28
KR100699422B1 (ko) 2007-03-28
EP0948541A2 (de) 1999-10-13
KR20060030006A (ko) 2006-04-07
NO993341L (no) 1999-09-06
HUP9904596A1 (hu) 2000-06-28
NZ336610A (en) 2001-07-27
WO1998030590A9 (en) 1999-08-19
DK1645566T3 (da) 2010-09-27
DE69735603T2 (de) 2006-11-30
CN1254347A (zh) 2000-05-24
ATE321784T1 (de) 2006-04-15
WO1998030590A3 (en) 1998-12-10
EP1645566A2 (de) 2006-04-12
HUP9904596A3 (en) 2000-07-28
CZ298937B6 (cs) 2008-03-19
SI1645566T1 (sl) 2010-11-30
PT948541E (pt) 2006-07-31
JP2001508439A (ja) 2001-06-26
EP0948541B1 (de) 2006-03-29
EP1645566A3 (de) 2006-10-11
JP3963482B2 (ja) 2007-08-22
DE69739912D1 (de) 2010-07-29
CN1137898C (zh) 2004-02-11
EP2206725A1 (de) 2010-07-14
RU2198182C2 (ru) 2003-02-10
CA2276614A1 (en) 1998-07-16
IL130794A0 (en) 2001-01-28
SI0948541T1 (sl) 2006-06-30
HK1026215A1 (en) 2000-12-08
PT1645566E (pt) 2010-08-31
CZ239899A3 (cs) 2000-01-12
AU741584B2 (en) 2001-12-06
ES2258286T3 (es) 2006-08-16
NO993341D0 (no) 1999-07-06
PL191898B1 (pl) 2006-07-31
PL334438A1 (en) 2000-02-28
DE69735603D1 (de) 2006-05-18
AR051906A2 (es) 2007-02-14
AR038552A2 (es) 2005-01-19
WO1998030590A2 (en) 1998-07-16
DK0948541T3 (da) 2006-07-17

Similar Documents

Publication Publication Date Title
ATE471342T1 (de) Parathyroidhormon analoge
DE69729021D1 (de) Flächiges Implantat
ID22500A (id) Turunan sulfonamida
DE69805692D1 (de) Uhrenarmband
ATE277008T1 (de) Vitamin d3 analoge
DE59712097D1 (de) Elektronenstrahl-Linse
DE69812435T2 (de) Fördervorrichtung
FI103220B1 (fi) Näyttölaite
DE69917011D1 (de) Handgelenkprothese
DE59712120D1 (de) Kommunikationseinrichtung
DE59801983D1 (de) Fördereinrichtung
ID20979A (id) Pesawat penggerak piringan
DE69814269D1 (de) Prothesenanordnung
ATE238278T1 (de) Fluorinierte vitamin d3 analoge
DE59812757D1 (de) Substituierte tetrahydro-naphtaline und analoge verbindungen
NO975818D0 (no) Sandblåsingsmaterialer
FI970798A0 (fi) List foer en avvattningsanordning i en pappersmaskin
ATA182397A (de) Armbanduhr
FR2758079B1 (fr) Implant intra-corneen
NO975819D0 (no) Sandblåsingsmaterialer
ATA193897A (de) Rahmenförmiges bauelement
KR970058738U (ko) 로울러식 방충망
ATA31197A (de) Gewehr
KR980005804U (ko) 통신기 케이스
DE69805694D1 (de) Uhrengehäuse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1645566

Country of ref document: EP